• 1899 Citations
  • 28 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where E. Rásó is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
tiazofurin Medicine & Life Sciences
Integrins Medicine & Life Sciences
Arachidonate 12-Lipoxygenase Medicine & Life Sciences
Liver Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 1899 Citations
  • 28 h-Index
  • 73 Article
  • 1 Chapter
  • 1 Conference contribution

Selective Inhibition of HIF1α Expression by ZnSO4 Has Antitumoral Effects in Human Melanoma

Burián, Z., Ladányi, A., Barbai, T., Piurkó, V., Garay, T., Rásó, E. & Tímár, J., jan. 1 2019, (Accepted/In press) In : Pathology and Oncology Research.

Research output: Article

Zinc
Melanoma
Liver
Neoplasm Metastasis
SCID Mice

Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma

Reiniger, L., Téglási, V., Pipek, O., Rojkó, L., Glasz, T., Vágvölgyi, A., Kovalszky, I., Gyulai, M., Lohinai, Z., Rásó, E., Tímár, J., Döme, B., Szállási, Z. & Moldvay, J., jan. 1 2019, In : Acta Oncologica.

Research output: Article

Necrosis
Neoplasms
Adenocarcinoma of lung
Immunotherapy
Mutation

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): An open-label, non-randomized, multicenter, phase IV clinical trial

Markóczy, Z., Sárosi, V., Kudaba, I., Gálffy, G., Turay, Ü. Y., Demirkazik, A., Purkalne, G., Somfay, A., Pápai-Székely, Z., Rásó, E. & Ostoros, G., máj. 25 2018, In : BMC Cancer. 18, 1, 598.

Research output: Article

Phase IV Clinical Trials
Epidermal Growth Factor Receptor
Mutation
Disease-Free Survival
Safety